clinical decision support
The clinical support company will expand AI-driven partnership with the healthcare provider and begin rollout in 2024.
The healthcare system will translate its advanced algorithms pertaining to rapid response clinical scenarios into AvoMD's application.
The offering aims to help providers improve decision-making at the point of care while implementing generative AI effectively.
Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.
It uses a competitive learning approach against unlabelled data.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.
The clinical trial with Huntsville Heart Center is expected to be completed by October.
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
It plans to develop an in-house cloud platform.
The algorithm analyses EHR data and learns treatment patterns of type 2 diabetes patients.